U.S. Hospice Market Trends Analysis Report 2025-2030 | Dementia Leads Market Share Due to Elderly Dependency and Disability - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Hospice Market Size, Share & Trends Analysis Report by Type (Routine Home Care, Continuous Home Care, Inpatient Respite Care), Location (Hospice Center, Home Hospice Care), Diagnosis (Dementia, Cancer) with Growth Forecasts, 2025-2030" has been added to ResearchAndMarkets.com's offering.

The U.S. Hospice Market, valued at USD 29.92 billion in 2024, is anticipated to reach USD 39.09 billion by 2030 with a CAGR of 4.61%. This growth is driven by an aging population and the increasing prevalence of chronic disorders like cancer, dementia, and cardiovascular diseases, enhancing the demand for end-of-life care.

The industry is witnessing a strategic adoption of new technologies. Providers extend services to rural areas, showcasing the transformative impact of technology on care delivery. Innovations like telemedicine, predictive analytics, virtual reality, and artificial intelligence are increasingly deployed. A notable development in March 2023 saw WorldView collaborate with care coordinations to revolutionize home health and hospice care delivery through automation and patient engagement.

The COVID-19 pandemic posed challenges, affecting long-term forecasts and operational goals due to an initially reduced share of Medicare decedents enrolled for hospice care. In 2020, 47.8% of Medicare decedents were under hospice care, compared to 51.6% in 2019. Despite these setbacks, the pandemic accelerated technology adoption as patients preferred remote services, a trend poised to boost industry growth moving forward.

U.S. Hospice Market Report Highlights

• The Routine Homecare (RHC) segment dominated in 2024, capturing 92.98% of revenue share.
• Hospice centers held 86.32% of the market share in 2024, due to numerous benefits offered.
• The dementia segment accounted for 25.17% of the market share, attributed to dependency and disability factors affecting the elderly.

This report addresses:

• Market intelligence for informed decision-making.
• Comprehensive estimates and forecasts for 2018 to 2030.
• Growth opportunities and trend insights.
• Revenue forecasts by segment and region for assessment.
• Competitive strategies and market share analysis.
• Innovative product listings to stay competitive.
• Guidance on COVID-19 impact and market sustainability.

Key Attributes:

Report Attribute	Details
No. of Pages	90
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$29.92 Billion
Forecasted Market Value (USD) by 2030	$39.09 Billion
Compound Annual Growth Rate	4.6%
Regions Covered	United States

Companies Featured

• Chemed Corporation (VITAS Healthcare)
• LHC Group, Inc. (UnitedHealth Group)
• Amedisys
• Gentiva
• Brookdale Senior Living, Inc
• Crossroads Hospice (Agape Care Group)
• Seasons Hospice
• Oklahoma Palliative & Hospice Care
• Compassus
• Chapters Health System

For more information about this report visit https://www.researchandmarkets.com/r/m6b2d0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.